NKARTA INC's ticker is NKTX and the CUSIP is 65487U108. A total of 85 filers reported holding NKARTA INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,849,129 | -36.5% | 7,805,129 | 0.0% | 0.21% | -33.7% |
| Q2 2023 | $17,093,233 | -38.3% | 7,805,129 | 0.0% | 0.32% | -48.5% |
| Q1 2023 | $27,708,208 | -40.7% | 7,805,129 | 0.0% | 0.63% | -33.9% |
| Q4 2022 | $46,752,723 | -54.5% | 7,805,129 | 0.0% | 0.95% | -56.7% |
| Q3 2022 | $102,716,000 | +6.8% | 7,805,129 | 0.0% | 2.19% | -14.5% |
| Q2 2022 | $96,159,000 | +50.8% | 7,805,129 | +39.2% | 2.56% | +84.2% |
| Q1 2022 | $63,786,000 | -25.9% | 5,605,129 | 0.0% | 1.39% | -8.2% |
| Q4 2021 | $86,039,000 | -44.8% | 5,605,129 | 0.0% | 1.52% | -29.8% |
| Q3 2021 | $155,879,000 | -12.2% | 5,605,129 | 0.0% | 2.16% | -24.2% |
| Q2 2021 | $177,627,000 | -3.7% | 5,605,129 | 0.0% | 2.85% | +2.5% |
| Q1 2021 | $184,409,000 | -46.5% | 5,605,129 | 0.0% | 2.78% | -42.3% |
| Q4 2020 | $344,547,000 | +104.5% | 5,605,129 | 0.0% | 4.82% | +56.3% |
| Q3 2020 | $168,490,000 | – | 5,605,129 | – | 3.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 2,034,703 | $31,233,000 | 6.06% |
| Novo Holdings A/S | 2,793,864 | $42,886,000 | 2.03% |
| RA Capital Management | 5,605,129 | $86,039,000 | 1.52% |
| Deep Track Capital, LP | 1,264,426 | $19,409,000 | 1.37% |
| NEA Management Company, LLC | 2,904,974 | $44,591,000 | 0.90% |
| Vivo Capital, LLC | 512,225 | $7,863,000 | 0.47% |
| Pinz Capital Management, LP | 40,000 | $614,000 | 0.24% |
| Rock Springs Capital Management LP | 507,248 | $7,786,000 | 0.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 40,200 | $617,000 | 0.14% |
| EMC Capital Management | 12,548 | $193,000 | 0.10% |